Symptoms of neuronal damage include hypometabolism on fluorodeoxyglucose-PET (FDG-PET), elevated tau and/or phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF), or cortical atrophy on magnetic resonance imaging (MRI). The gene discussed is MAPT; the disease is Cerebral cortical atrophy.